Jeffrey L. Elliott - Publications

University of Texas Southwestern Medical Center, Dallas, TX, United States 

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Williams JR, Trias E, Beilby PR, Lopez NI, Labut EM, Samuel Bradford C, Roberts BR, McAllum EJ, Crouch PJ, Rhoads TW, Pereira C, Son M, Elliott JL, Franco MC, Estévez AG, et al. Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the copper-chaperone-for-SOD. Neurobiology of Disease. PMID 26826269 DOI: 10.1016/j.nbd.2016.01.020  0.56
2014 King IN, Yartseva V, Salas D, Kumar A, Heidersbach A, Ando DM, Stallings NR, Elliott JL, Srivastava D, Ivey KN. The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex. The Journal of Biological Chemistry. 289: 14263-71. PMID 24719334 DOI: 10.1074/Jbc.M114.561902  0.56
2014 Son M, Elliott JL. Mitochondrial defects in transgenic mice expressing Cu,Zn superoxide dismutase mutations: the role of copper chaperone for SOD1. Journal of the Neurological Sciences. 336: 1-7. PMID 24269091 DOI: 10.1016/j.jns.2013.11.004  0.56
2013 Stallings NR, Puttaparthi K, Dowling KJ, Luther CM, Burns DK, Davis K, Elliott JL. TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. Plos One. 8: e71793. PMID 23967244 DOI: 10.1371/Journal.Pone.0071793  0.56
2011 Son M, Srikanth U, Puttaparthi K, Luther C, Elliott JL. Biochemical properties and in vivo effects of the SOD1 zinc-binding site mutant (H80G). Journal of Neurochemistry. 118: 891-901. PMID 21692800 DOI: 10.1111/j.1471-4159.2011.07360.x  0.56
2011 Sadeghian H, O'Suilleabhain PE, Battiste J, Elliott JL, Trivedi JR. Huntington chorea presenting with motor neuron disease. Archives of Neurology. 68: 650-2. PMID 21555641 DOI: 10.1001/archneurol.2011.76  0.56
2011 Son M, Elliott JL. ALS and the Copper Chaperone CCS Protein Chaperones and Protection From Neurodegenerative Diseases. 315-357. DOI: 10.1002/9781118063903.ch10  0.56
2010 Sadeghian H, Chitnis S, Elliott JL. Deep brain stimulation artifact in needle electromyography. Archives of Neurology. 67: 1030. PMID 20697061 DOI: 10.1001/archneurol.2010.183  0.56
2010 Stallings NR, Puttaparthi K, Luther CM, Burns DK, Elliott JL. Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiology of Disease. 40: 404-14. PMID 20621187 DOI: 10.1016/J.Nbd.2010.06.017  0.56
2010 Hu W, Nessler S, Hemmer B, Eagar TN, Kane LP, Leliveld SR, Müller-Schiffmann A, Gocke AR, Lovett-Racke A, Ben LH, Hussain RZ, Breil A, Elliott JL, Puttaparthi K, Cravens PD, et al. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling. Brain : a Journal of Neurology. 133: 375-88. PMID 20145049 DOI: 10.1093/Brain/Awp298  0.56
2009 Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (New York, N.Y.). 326: 1549-54. PMID 20007902 DOI: 10.1126/Science.1181046  0.56
2009 Son M, Fu Q, Puttaparthi K, Matthews CM, Elliott JL. Redox susceptibility of SOD1 mutants is associated with the differential response to CCS over-expression in vivo. Neurobiology of Disease. 34: 155-62. PMID 19320055 DOI: 10.1016/j.nbd.2009.01.005  0.56
2008 Park S, Ramnarain DB, Hatanpaa KJ, Mickey BE, Saha D, Paulmurugan R, Madden CJ, Wright PS, Bhai S, Ali MA, Puttaparthi K, Hu W, Elliott JL, Stuve O, Habib AA. The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway. Embo Reports. 9: 766-73. PMID 18566599 DOI: 10.1038/Embor.2008.102  0.56
2008 Proescher JB, Son M, Elliott JL, Culotta VC. Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS. Human Molecular Genetics. 17: 1728-37. PMID 18337307 DOI: 10.1093/Hmg/Ddn063  0.56
2008 Son M, Leary SC, Romain N, Pierrel F, Winge DR, Haller RG, Elliott JL. Isolated cytochrome c oxidase deficiency in G93A SOD1 mice overexpressing CCS protein. The Journal of Biological Chemistry. 283: 12267-75. PMID 18334481 DOI: 10.1074/Jbc.M708523200  0.56
2007 Puttaparthi K, Van Kaer L, Elliott JL. Assessing the role of immuno-proteasomes in a mouse model of familial ALS. Experimental Neurology. 206: 53-8. PMID 17482163 DOI: 10.1016/j.expneurol.2007.03.024  0.56
2007 Son M, Puttaparthi K, Kawamata H, Rajendran B, Boyer PJ, Manfredi G, Elliott JL. Overexpression of CCS in G93A-SOD1 mice leads to accelerated neurological deficits with severe mitochondrial pathology. Proceedings of the National Academy of Sciences of the United States of America. 104: 6072-7. PMID 17389365 DOI: 10.1073/pnas.0610923104  0.56
2006 Krishnan U, Son M, Rajendran B, Elliott JL. Novel mutations that enhance or repress the aggregation potential of SOD1. Molecular and Cellular Biochemistry. 287: 201-11. PMID 16583143 DOI: 10.1007/s11010-005-9112-4  0.56
2005 Puttaparthi K, Elliott JL. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Experimental Neurology. 196: 441-51. PMID 16242125 DOI: 10.1016/j.expneurol.2005.08.027  0.56
2004 Elliott JL. Beginning to understand hereditary spastic paraplegia atlastin. Archives of Neurology. 61: 1842-3. PMID 15596602 DOI: 10.1001/archneur.61.12.1842  0.56
2004 Miller RG, Moore DH, Jackson CE. Western ALS Study Group. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 121-4. PMID 15512892 DOI: 10.1080/17434470410019988  0.56
2003 Puttaparthi K, Wojcik C, Rajendran B, DeMartino GN, Elliott JL. Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes. Journal of Neurochemistry. 87: 851-60. PMID 14622116 DOI: 10.1046/j.1471-4159.2003.02028.x  0.56
2003 Son M, Cloyd CD, Rothstein JD, Rajendran B, Elliott JL. Aggregate formation in Cu,Zn superoxide dismutase-related proteins. The Journal of Biological Chemistry. 278: 14331-6. PMID 12551935 DOI: 10.1074/jbc.M211698200  0.56
2002 Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8790-6. PMID 12388585 DOI: 10.1523/Jneurosci.22-20-08790.2002  0.56
2001 Elliott JL. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Research. Molecular Brain Research. 95: 172-8. PMID 11687290 DOI: 10.1016/S0169-328X(01)00242-X  0.56
2001 Son M, Fathallah-Shaykh HM, Elliott JL. Survival in a transgenic model of FALS is independent of iNOS expression. Annals of Neurology. 50: 273. PMID 11506415 DOI: 10.1002/Ana.1104  0.56
2001 Elliott JL. Zinc and copper in the pathogenesis of amyotrophic lateral sclerosis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 1169-85. PMID 11474839 DOI: 10.1016/S0278-5846(01)00185-3  0.56
2000 Honig LS, Chambliss DD, Bigio EH, Carroll SL, Elliott JL. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology. 55: 1082-8. PMID 11071482 DOI: 10.1212/Wnl.55.8.1082  0.56
2000 Gong YH, Elliott JL. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis. Experimental Neurology. 162: 27-36. PMID 10716886 DOI: 10.1006/exnr.2000.7323  0.56
2000 Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 660-5. PMID 10632595 DOI: 10.1523/Jneurosci.20-02-00660.2000  0.56
1999 Elliott JL. Experimental models of amyotrophic lateral sclerosis. Neurobiology of Disease. 6: 310-20. PMID 10527800 DOI: 10.1006/nbdi.1999.0266  0.56
1999 Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP, Bryan WW, Barohn RJ. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology. 53: 1071-6. PMID 10496268 DOI: 10.1212/WNL.53.5.1071  0.56
1999 Nevo Y, Al-Lozi M, Parsadanian AS, Elliott JL, Connolly AM, Pestronk A. Mutation analysis in Emery-Dreifuss muscular dystrophy. Pediatric Neurology. 21: 456-9. PMID 10428430 DOI: 10.1016/S0887-8994(99)00023-5  0.56
1998 Elliott JL. A clearer view of upper motor neuron dysfunction in amyotrophic lateral sclerosis. Archives of Neurology. 55: 910-2. PMID 9678307 DOI: 10.1001/archneur.55.7.910  0.56
1997 Elliott JL, Kwon JM, Goodfellow PJ, Yee WC. Hereditary motor and sensory neuropathy IIB: clinical and electrodiagnostic characteristics. Neurology. 48: 23-8. PMID 9008488 DOI: 10.1212/WNL.48.1.23  0.56
1996 Elliott JL, Snider WD. Motor neuron growth factors. Neurology. 47: S47-53. PMID 8858051 DOI: 10.1212/Wnl.47.4_Suppl_2.47S  0.56
1996 Deckwerth TL, Elliott JL, Knudson CM, Johnson EM, Snider WD, Korsmeyer SJ. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron. 17: 401-11. PMID 8816704 DOI: 10.1016/S0896-6273(00)80173-7  0.56
1996 Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH, Scott RW, Snider WD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genetics. 13: 43-7. PMID 8673102 DOI: 10.1038/Ng0596-43  0.56
1995 Elliott JL, Snider WD. Parvalbumin is a marker of ALS-resistant motor neurons. Neuroreport. 6: 449-52. PMID 7766841 DOI: 10.1097/00001756-199502000-00011  0.56
1995 Kwon JM, Elliott JL, Yee WC, Ivanovich J, Scavarda NJ, Moolsintong PJ, Goodfellow PJ. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. American Journal of Human Genetics. 57: 853-8. PMID 7573046  0.56
1994 Sanner C, Elliott JL, Snider WD. Upregulation of NMDARI mRNA induced by MK-801 is associated with massive death of axotomized motor neurones in adult rats. Neurobiology of Disease. 1: 121-9. PMID 9173991 DOI: 10.1006/nbdi.1994.0015  0.56
1994 Elliott JL, Pestronk A. Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin. Neurology. 44: 967-8. PMID 8190308 DOI: 10.1212/Wnl.44.5.967  0.56
1994 Pestronk A, Lopate G, Kornberg AJ, Elliott JL, Blume G, Yee WC, Goodnough LT. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide. Neurology. 44: 2027-31. PMID 7969954 DOI: 10.1212/WNL.44.11.2028  0.56
1993 Yan Q, Elliott JL, Matheson C, Sun J, Zhang L, Mu X, Rex KL, Snider WD. Influences of neurotrophins on mammalian motoneurons in vivo. Journal of Neurobiology. 24: 1555-77. PMID 8301265 DOI: 10.1002/neu.480241202  0.56
1992 Ruit KG, Elliott JL, Osborne PA, Yan Q, Snider WD. Selective dependence of mammalian dorsal root ganglion neurons on nerve growth factor during embryonic development. Neuron. 8: 573-87. PMID 1550679 DOI: 10.1016/0896-6273(92)90284-K  0.56
1992 Snider WD, Elliott JL, Yan Q. Axotomy-induced neuronal death during development. Journal of Neurobiology. 23: 1231-46. PMID 1469386 DOI: 10.1002/neu.480230913  0.56
1992 Yan Q, Elliott J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature. 360: 753-5. PMID 1281520 DOI: 10.1038/360753a0  0.56
Show low-probability matches.